Edwards Lifesciences Expands Singapore Manufacturing Facility

Company News

Edwards Lifesciences Corporation (NYSE:EW), focused on heart valves and hemodynamic monitoring, announced today that it has expanded its heart valve manufacturing facility in Singapore, to accommodate growing demand for tissue heart valves.

Edwards Lifesciences Corporation (NYSE:EW), focused on heart valves and hemodynamic monitoring, announced today that it has expanded its heart valve manufacturing facility in Singapore, to accommodate growing demand for tissue heart valves.

As quoted in the press release:

This expansion of Edwards’ Singapore manufacturing facility will more than double the size of the current building to approximately 24,000 square meters, while adding offices and laboratories, a large clean room and training facilities. With this new project, Edwards has invested approximately S$95 million in Singapore since 2005.

Click here for the full press release by Edwards Lifesciences Corporation (NYSE:EW)

The Conversation (0)
Ă—